Effects of clodronate on early alveolar bone remodeling and root resorption related to orthodontic forces: A histomorphometric analysis

Van Beek, 2002, Bone, 30, 64, 10.1016/S8756-3282(01)00655-X Plosker, 1994, Clodronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease, Drugs, 47, 945, 10.2165/00003495-199447060-00007 Bonabello, 2003, Long-term analgesic effect of clodronate in rodents, Bone, 33, 567, 10.1016/S8756-3282(03)00229-1 Rodan, 1996, Bisphosphonates: mechanisms of action, J Clin Invest, 97, 2692, 10.1172/JCI118722 Meunier, 1999, Diagnosis and management of osteoporosis in postmenopausal women: clinical guidelines. International Committee for Osteoporosis Clinical Guidelines, Clin Ther, 21, 1025, 10.1016/S0149-2918(99)80022-8 Kanis, 1996, Clodronate decreases the frequency of skeletal metastases in women with breast cancer, Bone, 19, 663, 10.1016/S8756-3282(96)00285-2 Filipponi, 1996, Cyclical intravenous clodronate in postmenopausal osteoporosis: results of a long-term clinical trial, Bone, 18, 179, 10.1016/8756-3282(95)00442-4 Reginster, 2000, Vertebral Efficacy with Risedronate Therapy (VERT) Study Group, Osteoporos Int, 11, 83, 10.1007/s001980050010 McCloskey, 2001, Long-term follow-up of a prospective, double-blind, placebo-controlled randomized trial of clodronate in multiple myeloma, Br J Haematol, 113, 1035, 10.1046/j.1365-2141.2001.02851.x Flanagan, 1991, Inhibition of bone resorption by bisphosphonates: interactions between bisphosphonates, osteoclasts, and bone, Calcif Tissue Int, 49, 407, 10.1007/BF02555852 Horie, 2003, Clodronate stimulates bone formation as well as inhibits bone resorption and increases bone mineral density in rats fed a low-calcium diet, J Med Dent Sci, 50, 121 Adachi, 1994, Effects of topical administration of a bisphosphonate (risedronate) on orthodontic tooth movements in rats, J Dent Res, 73, 1478, 10.1177/00220345940730081301 Igarashi, 1994, Anchorage and retentive effects of a bisphosphonate (AHBuBP) on tooth movements in rats, Am J Orthod Dentofacial Orthop, 106, 279, 10.1016/S0889-5406(94)70048-6 Igarashi, 1996, Inhibitory effect of the topical administration of a bisphosphonate (risedronate) on root resorption incident to orthodontic tooth movement in rats, J Dent Res, 75, 1644, 10.1177/00220345960750090501 Liu, 2004, Effects of local administration of clodronate on orthodontic tooth movement and root resorption in rats, Eur J Orthod, 26, 469, 10.1093/ejo/26.5.469 Rogers, 2000, Cellular and molecular mechanisms of action of bisphosphonates, Cancer, 88, 2961, 10.1002/1097-0142(20000615)88:12+<2961::AID-CNCR12>3.0.CO;2-L Frith, 2001, The molecular mechanism of action of the antiresorptive and anti-inflammatory drug clodronate: evidence for the formation in vivo of a metabolite that inhibits bone resorption and causes osteoclast and macrophage apoptosis, Arthritis Rheum, 44, 2201, 10.1002/1529-0131(200109)44:9<2201::AID-ART374>3.0.CO;2-E Leiker, 1995, The effects of exogenous prostaglandins on orthodontic tooth movement in rats, Am J Orthod Dentofacial Orthop, 108, 380, 10.1016/S0889-5406(95)70035-8 Rody, 2001, Osteoclast recruitment to sites of compression in orthodontic tooth movement, Am J Orthod Dentofacial Orthop, 120, 477, 10.1067/mod.2001.118623 Capparelli, 2003, Sustained antiresorptive effects after a single treatment with human recombinant osteoprotegerin (OPG): a pharmacodynamic and pharmacokinetic analysis in rats, J Bone Miner Res, 18, 852, 10.1359/jbmr.2003.18.5.852 Oyonarte, 2005, Peri-implant bone response to orthodontic loading: part 2. Implant surface geometry and its effect on regional bone remodeling, Am J Orthod Dentofacial Orthop, 128, 182, 10.1016/j.ajodo.2004.02.024 Donath, 1982, A method for the study of undecalcified bones and teeth with attached soft tissues. The Säge-Schliff (sawing and grinding) technique, J Oral Pathol, 11, 318, 10.1111/j.1600-0714.1982.tb00172.x Seifi, 2003, The effect of prostaglandin E2 and calcium gluconate on orthodontic tooth movement and root resorption in rats, Eur J Orthod, 25, 199, 10.1093/ejo/25.2.199 Parfitt, 1988, Bone histomorphometry: standardization of nomenclature, symbols and units (summary of proposed system), Bone, 9, 67, 10.1016/8756-3282(88)90029-4 Pilliar, 1998, Overview of surface variability of metallic endosseous dental implants: textured and porous surface-structured designs, Implant Dent, 7, 305, 10.1097/00008505-199807040-00009 Talic, 2006, Inhibition of orthodontically induced root resorption with echistatin, an RGD-containing peptide, Am J Orthod Dentofacial Orthop, 129, 252, 10.1016/j.ajodo.2004.11.030 Verna, 2003, Bone turnover rate in rats does not influence root resorption induced by orthodontic treatment, Eur J Orthod, 25, 359, 10.1093/ejo/25.4.359 Pavlin, 2000, Orthodontically stressed periodontium of transgenic mouse as a model for studying mechanical response in bone: the effect on the number of osteoblasts, Clin Orthod Res, 3, 55, 10.1034/j.1600-0544.2000.030202.x Keles, 2007, Inhibition of tooth movement by osteoprotegerin vs. pamidronate under conditions of constant orthodontic force, Eur J Oral Sci, 115, 131, 10.1111/j.1600-0722.2007.00433.x King, 1991, Histomorphometric study of alveolar bone turnover in orthodontic tooth movement, Bone, 12, 401, 10.1016/8756-3282(91)90029-I Halasy-Nagy, 2001, Inhibition of bone resorption by alendronate and risedronate does not require osteoclast apoptosis, Bone, 29, 553, 10.1016/S8756-3282(01)00615-9 Liu, 2006, Clodronate inhibits PGE(2) production in compressed periodontal ligament cells, J Dent Res, 85, 757, 10.1177/154405910608500813 Graham, 2006, Bisphosphonates and orthodontics: clinical implications, J Clin Orthod, 40, 425 Zahrowski, 2007, Bisphosphonate treatment: an orthodontic concern calling for a proactive approach, Am J Orthod Dentofacial Orthop, 131, 311, 10.1016/j.ajodo.2006.09.035 Zahrowski, 2009, Optimizing orthodontic treatment in patients taking bisphosphonates for osteoporosis, Am J Orthod Dentofacial Orthop, 135, 361, 10.1016/j.ajodo.2008.08.017 McCloskey, 2004, Clodronate reduces vertebral fracture risk in women with postmenopausal or secondary osteoporosis: results of a double-blind, placebo-controlled 3-year study, J Bone Miner Res, 19, 728, 10.1359/jbmr.040116 Giannini, 1993, Effects of one-year cyclical treatment with clodronate on postmenopausal bone loss, Bone, 14, 137, 10.1016/8756-3282(93)90240-B Berenson, 2001, Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases, Cancer, 91, 1191, 10.1002/1097-0142(20010401)91:7<1191::AID-CNCR1119>3.0.CO;2-0 Reid, 2002, Intravenous zoledronic acid in postmenopausal women with low bone mineral density, N Eng J Med, 346, 653, 10.1056/NEJMoa011807